C-Reactive Protein and Cardiovascular Risk in the General Population: A European Heart Journal Study by Berkan Kurt et al.
Berkan Kurt, Resident Physician in Cardiology and Internal Medicine at Uniklinik RWTH Aachen, posted on LinkedIn:
“Deeply grateful to share that our article “C-reactive protein and cardiovascular risk in the general population” has now been published in the European Heart Journal.
In 448 653 adults without known ASCVD, a single hsCRP measurement showed strong stability over time, displayed long-term inflammatory risk, and independently predicted MACE, CV death and all-cause mortality across clinically relevant subgroups, including SMuRF-less but inflamed individuals. hsCRP ranked among the strongest predictors of CV outcomes and added incremental value to SCORE2-based risk prediction. 
Our findings underscore residual inflammatory risk as an additional, relevant dimension in primary prevention. Routine hsCRP assessment should be considered for inclusion in future guidelines to refine CV risk assessment and to improve prevention strategies in patients without a history of ASCVD.
Sincerely thankful to my mentor Florian Kahles for his continuous support and guidance, my colleague Martin Reugels for the outstanding work together on this project, and to all co-authors and international colleagues for their generous collaboration and the privilege of working together with leading experts in the field.
Open access article”
Title: C-reactive protein and cardiovascular risk in the general population
Authors: Berkan Kurt, Martin Reugels, Kai M Schneider, Jens Spiesshoefer, Andrea Milzi, Alexander Gombert, Christopher B Fordyce, Florian A Wenzl, Neha J Pagidipati, Viviane Rocha, Marat Fudim, Abhinav Sharma, Michael Lehrke, Hiroaki Shimokawa, Giovanna Liuzzo, Lale Tokgozoglu, Filippo Crea, Thomas F Lüscher, Peter Libby, Paul M Ridker, Nikolaus Marx, Carolin V Schneider, Florian Kahles
Get the latest from Hemostasis Today.
-
Mar 17, 2026, 18:11Ossama Mansour: Landmark MENA Guidelines for Acute Ischemic Stroke Management
-
Mar 17, 2026, 17:48Andrea Van Beek: Improving DOAC Adherence Saves Lives
-
Mar 17, 2026, 17:43Soumen Bhattacharyya: Microangiopathic Hemolytic Anemia Is Often a Hematologic Clue to Underlying Malignancy
-
Mar 17, 2026, 17:37Peter Bou Dib: New Insights on Factor VIII and the Musculoskeletal System
-
Mar 17, 2026, 17:31Armghan Ans: The 2026 Stroke Guidelines Are Excellent, Now the Hard Part
-
Mar 17, 2026, 17:26Danny Hsu: Navigating a Rebalanced Hemostatic State in Decompensated Cirrhosis
-
Mar 17, 2026, 17:21Matías J Alet on Acute Ischemic Stroke With Low NIHSS at NeuroQuality
-
Mar 17, 2026, 17:16S1PR4 Controls Platelet Fibrinogen Binding and Thrombus Formation – JTH
-
Mar 17, 2026, 15:55Mostafa Faisal Mohammed Saleh: Evidence-Based Recommendations for Hodgkin Lymphoma Management in LMICs